Literature DB >> 21659330

Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.

Klaas Heinemann1, Lothar A J Heinemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21659330     DOI： 10.1136/jfprhc-2011-14524

Source DB:  PubMed          Journal:  J Fam Plann Reprod Health Care        ISSN： 1471-1893


× No keyword cloud information.
  2 in total

1.  Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.

Authors:  Yana Vinogradova; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ       Date:  2015-05-26

2.  Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.

Authors:  Shiori Hasegawa; Toshinobu Matsui; Yuuki Hane; Junko Abe; Haruna Hatahira; Yumi Motooka; Sayaka Sasaoka; Akiho Fukuda; Misa Naganuma; Kouseki Hirade; Yukiko Takahashi; Yasutomi Kinosada; Mitsuhiro Nakamura
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.